SK Biopharm Advances Digital Epilepsy Management, Achieving World-Class Design Standards

SK Biopharm announced on the 20th that its self-developed mobile application for wearable devices, the 'Zero App,' won the Winner award in the Service Design category (Healthcare & Wellness) at the global design award, the iF Design Award 2023.

SK Biopharm's mobile application 'Zero App,' which won the main prize at the iF Design Award 2023 [Photo by SK Biopharm]

Following the Red Dot Design Award wins for two wearable devices this year (Zero Wired and Zero Earbud), SK Biopharm has once again been recognized for its design competitiveness with an app related to wearable devices.

The iF Design Award is considered one of the world's top three design awards, along with the Red Dot Design Award and the International Design Excellence Awards (IDEA). This year, over 11,000 entries were submitted from 56 countries worldwide.

The Zero App is a mobile application that records and analyzes biometric signals collected through wearable devices in real time. It was highly evaluated not only for its service functionality but also for its design differentiation and excellence in user experience (UX) and user interface (UI). The design of the Zero App was created in collaboration with Plus X, a brand experience design consulting firm responsible for branding and UX/UI design consulting for BTS and 29CM.

The Zero App helps manage diseases by recording and analyzing data collected through a wearable device dedicated to epilepsy, which measures complex biometric signals such as brain waves, heart rate variability, and movement in real time. SK Biopharm is operating 'Project Zero,' which aims for the complete elimination of seizures in epilepsy patients through five types of wearable devices and the Zero App.

This content was produced with the assistance of AI translation services.